We hypothesize that HLWDD alleviates NAFLD by enriching beneficial gut flora (e.g., Akkermansia), regulating gut-liver axis metabolites to activate LKB1/AMPK signaling, and restoring lipid oxidation (via CPT1A/PPARα) and amino acid homeostasis. Here, CPT1A is linked to metabolic dysfunction-associated steatotic liver disease.